A phase I trial of PD-1 deficient engineered T cells with CRISPR/Cas9 in patients with advanced non-small cell lung cancer.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Title: Journal of Clinical Oncology

Abbreviated Title: JCO

Publisher: American Society of Clinical Oncology (ASCO)

ISSN (Print): 0732-183X

ISSN (Electronic): 1527-7755

Publication date Created: May 20 2018

Publication date (Print): May 20 2018

Volume: 36

Issue: 15_suppl

Page: 3050

Affiliations

[1 ]Department of Thoracic Oncology, Cancer Center, West China Hospital, West China School of Clinical Medicine, Sichuan University, Chengdu, China;

[2 ]Department of Thoracic Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China;

[3 ]Chengdu MedGenCell, Co., Ltd, Chengdu, China;

[4 ]Department of Thoracic Cancer, Cancer Center, West China Hospital, Sichuan Univeristy, Chengdu, China;

[5 ]Center of GCP, West China Hospital, Sichuan University, Chengdu, China;

[6 ]Jacobi Medical Center, NYC Health Hospitals, Albert Einstein College of Medicine, NY, NY;

[7 ]Department of Thoracic Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China, Chengdu, China;

[8 ]Cancer Center, West China Hospital, Sichuan Univeristy, Chengdu, China;

[9 ]Department of Thoracic Oncology, Cancer Center, West China Hospital, Sichuan Universitity, Chengdu, China;

[10 ]State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China;

[11 ]Department of Respiratory and Critical care medicine,West China Hospital, Sichuan University, Chengdu, China;

Article

DOI: 10.1200/JCO.2018.36.15_suppl.3050

SO-VID: caf01cd5-2f26-4013-89b9-004136f50273

History

Data availability:

Comments

Comment on this article

scite_

Cited by 12

See all cited by